CHAVD.ORG: Keyword Density Checker

Total words: 2442 | 2-word phrases: 647 | 3-word phrases: 696 | 4-word phrases: 711

PAGE INFO

Title	Try to keep the title under 60 characters (0 characters)
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	the scripps research	3	0.43%
2	concepts our approach	3	0.43%
3	key concepts our	3	0.43%
4	our accomplishments scripps	3	0.43%
5	accomplishments scripps chavd	3	0.43%
6	scripps chavd team	3	0.43%
7	for hivaids vaccine	3	0.43%
8	publications news resources	3	0.43%
9	about key concepts	2	0.29%
10	investigator awards read	2	0.29%
11	hiv vaccine read	2	0.29%
12	strategies that induce	2	0.29%
13	an hiv vaccine	2	0.29%
14	scripps chavd announces	2	0.29%
15	immunization strategies that	2	0.29%
16	immunogens and immunization	2	0.29%
17	hivaids vaccine development	2	0.29%
18	consortium for hivaids	2	0.29%
19	our approach our	2	0.29%
20	scripps research institute	2	0.29%
21	copy and paste	2	0.29%
22	approach our accomplishments	2	0.29%
23	resources contact us	2	0.29%
24	scripps consortium for	2	0.29%
25	news resources contact	2	0.29%
26	broadly neutralizing antibodies	2	0.29%
27	as part of	1	0.14%
28	but if proposed	1	0.14%
29	bnabinducing regimen but	1	0.14%
30	regimen but if	1	0.14%

#	Keyword	Frequency	Density
1	key concepts our approach	3	0.42%
2	our accomplishments scripps chavd	3	0.42%
3	accomplishments scripps chavd team	3	0.42%
4	about key concepts our	2	0.28%
5	news resources contact us	2	0.28%
6	for hivaids vaccine development	2	0.28%
7	consortium for hivaids vaccine	2	0.28%
8	scripps consortium for hivaids	2	0.28%
9	the scripps research institute	2	0.28%
10	immunization strategies that induce	2	0.28%
11	publications news resources contact	2	0.28%
12	our approach our accomplishments	2	0.28%
13	approach our accomplishments scripps	2	0.28%
14	concepts our approach our	2	0.28%
15	but if proposed alone	1	0.14%
16	regimen but if proposed	1	0.14%
17	bnabinducing regimen but if	1	0.14%
18	as part of a	1	0.14%
19	validated as part of	1	0.14%
20	be validated as part	1	0.14%
21	but at all stages	1	0.14%
22	generally be validated as	1	0.14%
23	should generally be validated	1	0.14%
24	immunogens should generally be	1	0.14%
25	trimer immunogens should generally	1	0.14%
26	of sequential vaccination polishing	1	0.14%
27	stages of sequential vaccination	1	0.14%
28	all stages of sequential	1	0.14%
29	at all stages of	1	0.14%
30	during priming but at	1	0.14%
31	priming but at all	1	0.14%
32	of immune responses in	1	0.14%
33	in humans will be	1	0.14%
34	crucial to iterative vaccine	1	0.14%
35	to iterative vaccine design	1	0.14%
36	iterative vaccine design improvements	1	0.14%
37	immune responses in humans	1	0.14%
38	vaccine design improvements frequencies	1	0.14%
39	design improvements frequencies of	1	0.14%
40	responses in humans will	1	0.14%